why is everyone taking glp 1 The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 What Really Happens When You

The FDA sent 30 warning letters to telehealth companies in March alone, and by the end of April, they proposed taking semaglutide, tirzepatide, and liraglutide off the 503B Bulk Drug Substances List altogether

All-cause and cardiovascular-related mortality in CKD patients with and without heart failure: a population-based cohort study in Kaiser Permanente Southern California

Treating it as a series of isolated problems produces, at best, partial solutions

Patients should check with their insurance companies to understand coverage specifics

GLP-1 tapering and long-term weight management If youre taking a GLP-1 for type 2 diabetes, you will likely stay on your maintenance dose unless your doctor recommends otherwise